Pure Global

HbA1c Rapid Quantitative Test - India CDSCO Medical Device Registration

HbA1c Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_83cfafd97de1c476342478e3b83f1089_50fd5a818b73691059e9a68f8ad12243. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HbA1c Rapid Quantitative Test
UID: IMP/IVD/2022/000074_83cfafd97de1c476342478e3b83f1089_50fd5a818b73691059e9a68f8ad12243

Brand Name

Glycated Hemoglobin

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Aehealth HbA1c Rapid Quantitative Test along with Aehealth Fluorescence Immunoassay Analyzer (Glycated Hemoglobin) is intended for vitro quantitative determination of HbA1c in human blood

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing